Our editorial mission
Our goal is to make peptide-related topics easier to understand while avoiding unsafe medical claims.
Peptides are discussed in medicine, skincare, longevity, recovery, and online biohacking communities. Because these topics can affect health decisions, our pages are written with cautious language, evidence limits, and safety reminders.
What we cover
Peptide basics
Definitions, mechanisms, peptide vs protein comparisons, categories, and glossary-style explainers.
Evidence and limits
Human evidence, preclinical research, theoretical mechanisms, regulatory differences, and areas where evidence is incomplete.
Responsible framing
Red flags, clinician discussion points, lab context, and reminders that online products can differ from regulated preparations.
Editorial standards
Articles are prepared as educational explainers and reviewed for clarity, safety language, and separation between informational content and sponsored resources.
Health-related content rules
Health-related pages should describe evidence limits, distinguish human evidence from preclinical or theoretical discussion, and avoid presenting experimental compounds as approved treatments.
- We do not publish dosing charts, injection instructions, sourcing instructions, or self-treatment protocols.
- We avoid language such as “cures,” “treats,” “guarantees,” “reverses aging,” or “replaces medical care.”
- When symptoms may indicate a serious condition, content should direct readers to discuss concerns with a qualified clinician.
- When pages discuss hormones, sexual health, cognition, immune function, or chronic conditions, the page should include stronger medical-safety framing.
- When a compound is not approved for a specific consumer use, that uncertainty should be made clear.
Sources and evidence policy
When pages discuss scientific claims, they should use cautious wording and, when possible, point readers toward reputable sources such as government health agencies, medical reference sites, peer-reviewed literature, drug labels, or clinical trial records.
Higher-trust references
FDA, NIH, MedlinePlus, PubMed-indexed reviews, clinical guidelines, clinical trial registries, and official regulatory information.
What we clarify
Whether a discussion is based on human clinical evidence, animal research, lab research, theoretical mechanisms, or community discussion.
For peptide topics, product identity matters. An online product may not match the preparation, purity, concentration, delivery route, or regulatory status used in a study or medical context.
Sponsored resources and affiliate separation
Some pages may include sponsored or affiliate links. These links should be labeled and kept separate from the educational explanation.
- Affiliate links do not determine our educational conclusions.
- Sponsored blocks should not imply that a product is medically necessary or clinically recommended.
- Educational content should not be written as a product endorsement.
- Commercial resources are included as reader resources only, not as medical recommendations.
Corrections policy
Corrections may be made when wording is unclear, when a source is outdated, when a safety statement needs to be stronger, or when a page could be misunderstood as treatment guidance.
Review and update process
Pages may be reviewed when new evidence, safety concerns, regulatory updates, or wording issues are identified. Date labels may be updated when meaningful content changes are made.
Contact and feedback
Readers can contact us to report unclear wording, possible inaccuracies, outdated references, broken links, or safety concerns.
- Our pages are educational, not medical instructions.
- Health claims should be framed cautiously and with evidence limits.
- Sponsored resources must be separate from editorial conclusions.
- Corrections are made when clarity, safety, or source quality needs improvement.